Choose Language
Select a language for news translation.
Xander Zayas defends his WBA and WBO Light Middleweight titles against Jaron "Boots" Ennis on June 27, 2026, in a unification fight on DAZN PPV. This bout is c…
Puerto Rican boxer Xander Zayas defends his WBO and WBA super welterweight titles against undefeated Jaron Ennis at Barclays Center on June 27, live on DAZN in…
Aging activates stem cells that increase abdominal fat cell production, explaining midlife weight gain. Blocking these stem cells could prevent obesity-related…
Doping a 12-carbon ring with a single lithium atom increases its nonlinear optical response tenfold, offering a lightweight, tunable alternative to inorganic c…
Islam Makhachev and Sean O’Malley defended their UFC titles by winning unanimous decisions against Arman Tsarukyan and Petr Yan. Their wins solidify Makhachev …
CVS now offers GLP-1 weight-loss drugs via 9,000 pharmacies with $49 virtual visits, low-cost pricing, and free coaching, addressing prescription barriers and …
Eli Lilly’s stock hit a record high after Europe endorsed its leukemia drug Jaypirca and Medicare agreed to cover its weight-loss drugs Zepbound and Mounjaro, …
Oleksandr Usyk vacated his WBA, WBC, and IBF heavyweight titles without retiring, leaving the division open for contenders like Agit Kabayel and Daniel Dubois.…
Promoter Eddie Hearn claims he's "never been more confident" Anthony Joshua will knock out Tyson Fury in their heavyweight rematch on December 8. Hearn's confi…
GLP-1 drugs like Ozempic and Wegovy help average 15% fat loss, but up to 30% see less than 5% weight loss after six months; poor sleep, medications, and geneti…
Insurers are dropping coverage for weight-loss drugs like Zepbound and Wegovy due to high costs, leaving 24 million Americans without access by 2026. Coverage …
